«

»

Eli Lilly Covid-19 Antibody Treatment Trial Is Paused Due To ‘Potential Safety Concern’

President Trump has promoted the company’s antibody treatment in recent videos.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive